These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 38057118)

  • 21. D-Dimer Assay May Guide LMWH Treatment in Repeated Biochemical Pregnancy Losses in Women with Positive Antiphospholipid Antibody.
    Bao SH; Frempong ST; Ruan JL
    Clin Lab; 2020 Mar; 66(3):. PubMed ID: 32162875
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association between prophylactic low-molecular-weight heparin use in pregnancy and macrosomia: analysis of the Ottawa and Kingston birth cohort.
    Lowry DE; Corsi DJ; White RR; Guo M; Lanes A; Smith G; Rodger M; Wen SW; Walker M; Gaudet L
    J Thromb Haemost; 2019 Feb; 17(2):345-349. PubMed ID: 30552749
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The impact of low molecular weight heparin on obstetric outcomes among unexplained recurrent miscarriages complicated with methylenetetrahydrofolate reductase gene polymorphism.
    Cetin O; Karaman E; Cim N; Dirik D; Sahin HG; Kara E; Esen R
    Ginekol Pol; 2017; 88(5):260-265. PubMed ID: 28580572
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tumour necrosis factor inhibitor combined with intravenous immunoglobulin and heparin for treatment of recurrent spontaneous abortion: A two-centre, retrospective, cohort study.
    Jiang Y; Zou Q; Zhang N; Chen J; Chen X; You Q; Wu H
    J Clin Pharm Ther; 2022 Dec; 47(12):2320-2324. PubMed ID: 36511097
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Low molecular weight heparin and aspirin for recurrent pregnancy loss: results from the randomized, controlled HepASA Trial.
    Laskin CA; Spitzer KA; Clark CA; Crowther MR; Ginsberg JS; Hawker GA; Kingdom JC; Barrett J; Gent M
    J Rheumatol; 2009 Feb; 36(2):279-87. PubMed ID: 19208560
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of low-molecular-weight heparin in women undergoing frozen-thawed embryo transfer cycles: a retrospective cohort study.
    Sun B; Li L; Chen X; Sun Y
    BMC Pregnancy Childbirth; 2023 May; 23(1):335. PubMed ID: 37165315
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Meta-analysis of venous thromboembolism prophylaxis in medically Ill patients.
    Kanaan AO; Silva MA; Donovan JL; Roy T; Al-Homsi AS
    Clin Ther; 2007 Nov; 29(11):2395-405. PubMed ID: 18158080
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Low-molecular-weight heparin for women with unexplained recurrent pregnancy loss: a multicenter trial with a minimization randomization scheme.
    Schleussner E; Kamin G; Seliger G; Rogenhofer N; Ebner S; Toth B; Schenk M; Henes M; Bohlmann MK; Fischer T; Brosteanu O; Bauersachs R; Petroff D;
    Ann Intern Med; 2015 May; 162(9):601-9. PubMed ID: 25938990
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Aspirin, low molecular weight heparin, or both in preventing pregnancy complications in women with recurrent pregnancy loss and factor V Leiden mutation.
    Karadağ C; Akar B; Gönenç G; Aslancan R; Yılmaz N; Çalışkan E
    J Matern Fetal Neonatal Med; 2020 Jun; 33(11):1934-1939. PubMed ID: 31550962
    [No Abstract]   [Full Text] [Related]  

  • 30. A randomized, controlled clinical study of low-molecular-weight heparin improving pregnancy outcomes in PCOS women undergoing IVF: study protocol.
    Huang O; Ding H; Wu D; Zhang Q; Li W
    Trials; 2024 Jan; 25(1):16. PubMed ID: 38167499
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of low-molecular-weight heparins on anti-Xa peak levels and adverse reactions in Chinese patients with recurrent spontaneous abortion: a single-center, observational study.
    Bai W; Zhang X; Sun S; Wang Q; Li C; Zhang X; Zhao A
    BMC Pregnancy Childbirth; 2021 Oct; 21(1):683. PubMed ID: 34620101
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Aspirin and low-molecular weight heparin combination therapy effectively prevents recurrent miscarriage in hyperhomocysteinemic women.
    Chakraborty P; Banerjee S; Saha P; Nandi SS; Sharma S; Goswami SK; Chakravarty B; Kabir SN
    PLoS One; 2013; 8(9):e74155. PubMed ID: 24040195
    [TBL] [Abstract][Full Text] [Related]  

  • 33. ALIFE2 study: low-molecular-weight heparin for women with recurrent miscarriage and inherited thrombophilia--study protocol for a randomized controlled trial.
    de Jong PG; Quenby S; Bloemenkamp KW; Braams-Lisman BA; de Bruin JP; Coomarasamy A; David M; DeSancho MT; van der Heijden OW; Hoek A; Hutten BA; Jochmans K; Koks CA; Kuchenbecker WK; Mol BW; Torrance HL; Scheepers HC; Stephenson MD; Verhoeve HR; Visser J; de Vries JI; Goddijn M; Middeldorp S
    Trials; 2015 May; 16():208. PubMed ID: 25947329
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Comparison of platelet monitoring in patients receiving thromboprophylaxis with fondaparinux or a low molecular weight heparin. The Ariane study].
    Gouin-Thibault I; Liard F; Van-Ganse E; Vespa L; Gaudin AF; Nachit-Ouinekh F
    Presse Med; 2011 Sep; 40(9 Pt 1):e365-75. PubMed ID: 21515025
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Time to conception and time to live birth in women with unexplained recurrent miscarriage.
    Kaandorp SP; van Mens TE; Middeldorp S; Hutten BA; Hof MH; van der Post JA; van der Veen F; Goddijn M
    Hum Reprod; 2014 Jun; 29(6):1146-52. PubMed ID: 24682612
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Does Use of Low-Molecular-Weight Heparin during Pregnancy Influence the Risk of Prolonged Labor: A Population-Based Cohort Study.
    Sandström A; Cnattingius S; Wikström AK; Stephansson O; Iliadou AN
    PLoS One; 2015; 10(10):e0140422. PubMed ID: 26465918
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Low molecular weight heparin monotherapy for recurrent abortion with antiphospholipid system: A protocol of a systematic review.
    Ni L; Sun XQ; Zhao DX; Zhu ZW
    Medicine (Baltimore); 2019 Feb; 98(8):e14619. PubMed ID: 30813192
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chinese herbal medicines for unexplained recurrent miscarriage.
    Li L; Dou L; Leung PC; Chung TK; Wang CC
    Cochrane Database Syst Rev; 2016 Jan; 2016(1):CD010568. PubMed ID: 26760986
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Perinatal outcomes in a subsequent pregnancy among women who have experienced recurrent miscarriage: a retrospective cohort study.
    Field K; Murphy DJ
    Hum Reprod; 2015 May; 30(5):1239-45. PubMed ID: 25759495
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Outcomes of threatened abortions after anticoagulation treatment to prevent recurrent pregnancy loss.
    Rottenstreich A; Amsalem H; Kleinstern G; Kalish Y
    Reprod Biomed Online; 2017 Oct; 35(4):461-467. PubMed ID: 28756129
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.